Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

9342-8530 Quebec Inc DGCRF

Healthcare Biotechnology
Diagnocure Inc is a Canada based biotechnology company. It is primarily engaged in the business activity of development and commercialization of products relating to the diagnosis of cancer. The group generates its revenue from research and license agreement. The head office of the company is located in Quebec, Canada.


GREY:DGCRF - Post by User

9342-8530 Quebec Inc
Bullboard Posts
User Avatar Image
(0)
•••
Comment by ready2go1on Apr 21, 2011 9:59am
270 Views
Post# 18468424

RE: RE: RE: RE: GPRO aquires CUR?

RE: RE: RE: RE: GPRO aquires CUR?Gen-Probe reports April 28th and we could here something about an upcoming panel meeting in June. They however sometimes release news 3-4 days after a report. They would know by now if a meeting was taking place because they need to prepare. Their share price has been making nice gains so investors must be anticipating something. We are close to moving over $1.00 but late day market sells have been holding us back. Might not seem like much but I have friends looking to add to their positions but don't like investing under $1.00. When we cross over I would expect to see $1.10 to 1.20 and with news we will be on our way. I think the meeting will be the news that comes prior to an announcement of a partner that has bee talked about.
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities